Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Bupivacaine

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Phase 3 (1)
Phase 4 (3)

Trial Status

Unknown2
Completed2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Bupivacaine2
  • Iv Administration Of Midazolam To Investigate The Effects For Functional Nasal Endoscopic Surgery1
  • Tranexamic Acid1
  • Iv Administration Of Dex To Investigate The Effects For Functional Nasal Endoscopic Surgery1
  • Dexamethasone 2 Mg In Bupivacaine 0251

Active Sponsors

  • Cairo University3
  • Eye & ENT Hospital of Fudan University1
  • Loma Linda University1

Top Investigators

Related Conditions

  • Blood Loss During Surgery1
  • Bleeding1
  • Dexmedetomidine1
  • Heart Rate1
  • Nebulization1

Activity Timeline